Strides Pharma Science Ltd Analyst Rating
based on 4 analysts
75.00%
Buy
0.00%
Hold
25.00%
Sell
Based on 4 analysts offering long term price targets for Strides Pharma Science Ltd. An average target of ₹1494.75
Source: S&P Global Market Intelligence
Strides Pharma Science Ltd Share analysis
Strides Pharma Science Ltd price forecast by 4 analysts
Downside of
High
₹1954
Target
₹1494.75
Low
₹1175
Strides Pharma Science Ltd target price ₹1494.75, a slight downside of -8.24% compared to current price of ₹1638.55. According to 4 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Strides Pharma Science Ltd revenue growth forecast
Expected growth rate Q1, FY2026:26.76%
Forecast
Actual
Including amortisation and stock based compensations
Strides Pharma Science Ltd EPS growth forecast
EPS estimate Q1, FY2026:
Forecast
Actual
Source: S&P Global Market Intelligence
Strides Pharma Science Ltd Performance
Day's Low
Day's High
₹1,603.25₹1,67252 Week's Low
52 Week's High
₹467₹1,675
| Returns % | |
| 1 Month Return | + 19.87 % |
| 3 Month Return | + 71.22 % |
| 1 Year Return | + 235.68 % |
| Market Stats | |
| Previous Close | ₹1,628.90 |
| Open | ₹1,636.25 |
| Volume | 2.26L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹14,979.07Cr |
Strides Pharma Science Ltd Key Statistics
| P/E Ratio | 3193.92 |
| PEG Ratio | 367.96 |
| Market Cap | ₹14,979.07 Cr |
| P/B Ratio | 2.02 |
| EPS | -10.26 |
| Dividend Yield | 0.32 |
| Sector | Pharmaceuticals |
| ROE | 1.87 |
Strides Pharma Science Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹14,979.07 Cr | 72.88% | 0.66 | -₹95 Cr | ₹4,051 Cr | |
| NA | ₹207.23 Cr | 49.33% | 0.79 | ₹7 Cr | ₹339 Cr | |
| NA | ₹10.56 Cr | 219.49% | 0.50 | NA | NA | |
| BUY | ₹6,511.04 Cr | 14.02% | 0.62 | ₹48 Cr | ₹717 Cr | |
| NA | ₹28.64 Cr | 67.38% | 0.50 | NA | NA |
Strides Pharma Science Ltd Mutual Fund Holdings
About Strides Pharma Science Ltd
Share Price: ₹1638.55 per share as on 21 Oct, 2024 04:01 PM
Market Capitalisation: ₹14,979.07Cr as of today
Revenue: ₹1,087.51Cr as on June 2024 (Q2 24)
Net Profit: ₹68.31Cr as on June 2024 (Q2 24)
Listing date: 02 Feb, 2000
Chairperson Name: Arun Kumar
| Organisation | Strides Pharma Science Ltd |
| Headquarters | Bangaluru |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Strides Pharma Science Ltd
Strides Pharma Secures ₹801 Crore for OneSource - 16 Oct, 2024
Strides Pharma Science announced that its associate, OneSource Specialty Pharma, has secured ₹801 crore from institutional investors in a pre-listing round, boosting growth plans. Following this news, Strides shares surged 5.5%, reaching a 52-week high.
Strides Pharma Science Shows Strong Growth Potential - 02 Oct, 2024
Strides Pharma Science Limited, with a market cap of ₹128.83 billion, is trading significantly below its estimated fair value. Despite recent executive changes, the company forecasts a 65.18% annual earnings growth over the next three years, with a revenue growth rate of 11%, surpassing the Indian market average. This positions Strides as an attractive option for investors seeking undervalued stocks.
Strides Pharma Secures FDA Approval for Fluoxetine - 17 Sep, 2024
Strides Pharma's subsidiary, Strides Pharma Global Pte. Ltd., has received US FDA approval for its generic Fluoxetine tablets (60 mg), to be produced at its Puducherry facility.
Insights on Strides Pharma Science Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 month, STAR stock has moved up by 19.9%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 1.07K Cr → 1.10K Cr (in ₹), with an average increase of 2.7% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 24.57% to 26.71% in Jun 2024 quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, STAR has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, STAR has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 18.18 Cr → 70.2 Cr (in ₹), with an average increase of 74.1% per quarter
NEGATIVE IMPACTPromoter Holding Down
Promoters have decreased holdings from 25.88% to 25.86% in Jun 2024 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 10.57% to 10.50% in Jun 2024 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 31.50% to 28.87% in Jun 2024 quarter
Strides Pharma Science Ltd Financials
Index Inclusions
Strides Pharma Science Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 25.86% | ||
| Foreign Institutions | 26.71% | 8.69 | |
| Mutual Funds | 10.5% | ||
| Retail Investors | 28.87% | ||
| Others | 8.06% | 7.78 |
Strides Pharma Science Ltd Key Indicators
Strides Pharma Science Ltd Valuation
Strides Pharma Science Ltd in the last 5 years
Lowest (-179.24x)
July 5, 2021
Industry (58.10x)
October 18, 2024
Today (3193.92x)
October 18, 2024
Highest (3222.16x)
October 17, 2024
Strides Pharma Science Ltd Earnings and Dividends
Strides Pharma Science Ltd Earnings Results
Strides Pharma Science Ltd’s net profit jumped 1087.34% since last year same period to ₹70.20Cr in the Q1 2024-2025. On a quarterly growth basis, Strides Pharma Science Ltd has generated 286.14% jump in its net profits since last 3-months.
Read More about Earnings ResultsStrides Pharma Science Ltd Dividends May,2024
In the quarter ending March 2024, Strides Pharma Science Ltd has declared dividend of ₹2.50 - translating a dividend yield of 0.24%.
Read More about Dividends
Strides Pharma Science Ltd Technicals Summary
Bearish
Neutral
Bullish
Strides Pharma Science Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Strides Pharma Science Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Strides Pharma Science Ltd shares.
Strides Pharma Science Ltd (STAR) share price today is ₹1638.55
Strides Pharma Science Ltd is listed on NSE
Strides Pharma Science Ltd is listed on BSE
- Today’s highest price of Strides Pharma Science Ltd is ₹1672.
- Today’s lowest price of Strides Pharma Science Ltd is ₹1603.25.
PE Ratio of Strides Pharma Science Ltd is 3193.92
PE ratio = Strides Pharma Science Ltd Market price per share / Strides Pharma Science Ltd Earnings per share
Today’s traded volume of Strides Pharma Science Ltd(STAR) is 2.26L.
Today’s market capitalisation of Strides Pharma Science Ltd(STAR) is ₹14979.07Cr.
| Strides Pharma Science Ltd(STAR | Price |
|---|---|
52 Week High | ₹1675 |
52 Week Low | ₹467 |
Strides Pharma Science Ltd(STAR) share price is ₹1638.55. It is down -2.18% from its 52 Week High price of ₹1675
Strides Pharma Science Ltd(STAR) share price is ₹1638.55. It is up 250.87% from its 52 Week Low price of ₹467
| Strides Pharma Science Ltd(STAR | Returns |
|---|---|
1 Day Returns | 9.65% |
1 Month Returns | 19.87% |
3 Month Returns | 71.22% |
1 Year Returns | 235.68% |